Literature DB >> 34260850

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.

Johan Normark1, Linnea Vikström1, Yong-Dae Gwon1, Ida-Lisa Persson1, Alicia Edin1, Tove Björsell1, Andy Dernstedt1, Wanda Christ2, Staffan Tevell3, Magnus Evander1, Jonas Klingström2, Clas Ahlm4, Mattias Forsell4.   

Abstract

Entities:  

Year:  2021        PMID： 34260850     DOI： 10.1056/NEJMc2110716

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  61 in total

1.  Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.

Authors:  Annika Fendler; Lewis Au; Scott T C Shepherd; Fiona Byrne; Maddalena Cerrone; Laura Amanda Boos; Karolina Rzeniewicz; William Gordon; Benjamin Shum; Camille L Gerard; Barry Ward; Wenyi Xie; Andreas M Schmitt; Nalinie Joharatnam-Hogan; Georgina H Cornish; Martin Pule; Leila Mekkaoui; Kevin W Ng; Eleanor Carlyle; Kim Edmonds; Lyra Del Rosario; Sarah Sarker; Karla Lingard; Mary Mangwende; Lucy Holt; Hamid Ahmod; Richard Stone; Camila Gomes; Helen R Flynn; Ana Agua-Doce; Philip Hobson; Simon Caidan; Michael Howell; Mary Wu; Robert Goldstone; Margaret Crawford; Laura Cubitt; Harshil Patel; Mike Gavrielides; Emma Nye; Ambrosius P Snijders; James I MacRae; Jerome Nicod; Firza Gronthoud; Robyn L Shea; Christina Messiou; David Cunningham; Ian Chau; Naureen Starling; Nicholas Turner; Liam Welsh; Nicholas van As; Robin L Jones; Joanne Droney; Susana Banerjee; Kate C Tatham; Shaman Jhanji; Mary O'Brien; Olivia Curtis; Kevin Harrington; Shreerang Bhide; Jessica Bazin; Anna Robinson; Clemency Stephenson; Tim Slattery; Yasir Khan; Zayd Tippu; Isla Leslie; Spyridon Gennatas; Alicia Okines; Alison Reid; Kate Young; Andrew J S Furness; Lisa Pickering; Sonia Gandhi; Steve Gamblin; Charles Swanton; Emma Nicholson; Sacheen Kumar; Nadia Yousaf; Katalin A Wilkinson; Anthony Swerdlow; Ruth Harvey; George Kassiotis; James Larkin; Robert J Wilkinson; Samra Turajlic
Journal:  Nat Cancer       Date:  2021-10-27

2.  Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.

Authors:  Javier García-Pérez; María González-Pérez; María Castillo de la Osa; Alberto M Borobia; Luis Castaño; María Jesús Bertrán; Magdalena Campins; Antonio Portolés; David Lora; Mercedes Bermejo; Patricia Conde; Lourdes Hernández-Gutierrez; Antonio Carcas; Eunate Arana-Arri; Marta Tortajada; Inmaculada Fuentes; Ana Ascaso; María Teresa García-Morales; Humberto Erick de la Torre-Tarazona; José-Ramón Arribas; Natale Imaz-Ayo; Eugènia Mellado-Pau; Antonia Agustí; Carla Pérez-Ingidua; Agustín Gómez de la Cámara; Jordi Ochando; Cristobal Belda-Iniesta; Jesús Frías; José Alcamí; Mayte Pérez-Olmeda
Journal:  EClinicalMedicine       Date:  2022-07-01

3.  Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.

Authors:  Niklas Worm Andersson; Emilia Myrup Thiesson; Mona Vestergaard Laursen; Stine Hasling Mogensen; Jesper Kjær; Anders Hviid
Journal:  BMJ       Date:  2022-07-13

Review 4.  [Towards COVID-19 control through vaccination: obstacles, challenges and opportunities. SESPAS Report 2022].

Authors:  Pere Godoy; Jesús Castilla; Jenaro Astray; Sofía Godoy; José Tuells; Irene Barrabeig; Ángela Domínguez
Journal:  Gac Sanit       Date:  2022       Impact factor: 2.479

5.  Immunogenicity of COVID-19 Vaccination in Patients With End-Stage Renal Disease Undergoing Maintenance Hemodialysis: The Efficacy of a Mix-and-Match Strategy.

Authors:  Joon-Sung Park; Dohsik Minn; Susie Hong; Saeyoung Jeong; Soohyun Kim; Chang Hwa Lee; Bongyoung Kim
Journal:  J Korean Med Sci       Date:  2022-06-13       Impact factor: 5.354

6.  American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.

Authors:  Jeffrey R Curtis; Sindhu R Johnson; Donald D Anthony; Reuben J Arasaratnam; Lindsey R Baden; Anne R Bass; Cassandra Calabrese; Ellen M Gravallese; Rafael Harpaz; Andrew Kroger; Rebecca E Sadun; Amy S Turner; Eleanor Anderson Williams; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2022-05       Impact factor: 15.483

7.  Humoral immune response after different SARS-CoV-2 vaccination regimens.

Authors:  Ruben Rose; Franziska Neumann; Olaf Grobe; Thomas Lorentz; Helmut Fickenscher; Andi Krumbholz
Journal:  BMC Med       Date:  2022-01-21       Impact factor: 8.775

8.  Robust induction of neutralizing antibodies against the SARS-CoV-2 Delta variant after homologous Spikevax or heterologous Vaxzevria-Spikevax vaccination.

Authors:  Swantje I Hammerschmidt; Christoph Thurm; Berislav Bošnjak; Günter Bernhardt; Annegret Reinhold; Stefanie Willenzon; Christiane Ritter; Dirk Reinhold; Burkhart Schraven; Reinhold Förster
Journal:  Eur J Immunol       Date:  2022-01-07       Impact factor: 5.532

9.  Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.

Authors:  Annika Fendler; Scott T C Shepherd; Lewis Au; Katalin A Wilkinson; Mary Wu; Fiona Byrne; Maddalena Cerrone; Andreas M Schmitt; Nalinie Joharatnam-Hogan; Benjamin Shum; Zayd Tippu; Karolina Rzeniewicz; Laura Amanda Boos; Ruth Harvey; Eleanor Carlyle; Kim Edmonds; Lyra Del Rosario; Sarah Sarker; Karla Lingard; Mary Mangwende; Lucy Holt; Hamid Ahmod; Justine Korteweg; Tara Foley; Jessica Bazin; William Gordon; Taja Barber; Andrea Emslie-Henry; Wenyi Xie; Camille L Gerard; Daqi Deng; Emma C Wall; Ana Agua-Doce; Sina Namjou; Simon Caidan; Mike Gavrielides; James I MacRae; Gavin Kelly; Kema Peat; Denise Kelly; Aida Murra; Kayleigh Kelly; Molly O'Flaherty; Lauren Dowdie; Natalie Ash; Firza Gronthoud; Robyn L Shea; Gail Gardner; Darren Murray; Fiona Kinnaird; Wanyuan Cui; Javier Pascual; Simon Rodney; Justin Mencel; Olivia Curtis; Clemency Stephenson; Anna Robinson; Bhavna Oza; Sheima Farag; Isla Leslie; Aljosja Rogiers; Sunil Iyengar; Mark Ethell; Christina Messiou; David Cunningham; Ian Chau; Naureen Starling; Nicholas Turner; Liam Welsh; Nicholas van As; Robin L Jones; Joanne Droney; Susana Banerjee; Kate C Tatham; Mary O'Brien; Kevin Harrington; Shreerang Bhide; Alicia Okines; Alison Reid; Kate Young; Andrew J S Furness; Lisa Pickering; Charles Swanton; Sonia Gandhi; Steve Gamblin; David Lv Bauer; George Kassiotis; Sacheen Kumar; Nadia Yousaf; Shaman Jhanji; Emma Nicholson; Michael Howell; Susanna Walker; Robert J Wilkinson; James Larkin; Samra Turajlic
Journal:  Nat Cancer       Date:  2021-10-27

10.  Heterologous ChAdOx1-nCoV19-BNT162b2 vaccination provides superior immunogenicity against COVID-19.

Authors:  Christopher D Richardson
Journal:  Lancet Respir Med       Date:  2021-08-13       Impact factor: 30.700
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.